How We're Keeping You Safe | What Patients & Families Need to Know | Covid-19 Vaccines FAQs
Dr. Erickson specializes in research and clinical treatment involving persons with developmental disorders. His primary research focus is on new treatment development for Fragile X Syndrome (FXS), autism spectrum disorders (ASD), and other related disorders. He is the director of the Fragile X Research and Treatment Center and also serves as the director of research at the Kelly O'Leary Center for Autism Spectrum Disorders.
Dr. Pedapati has a strong interest in neuroplasticity and human electrophysiology. He primarily works using transcranial magnetic stimulation (TMS) in different patient populations including neuropsychiatric and developmental disorders.
Dr. Dominick completed her residency and fellowship at Cincinnati Children’s and has since joined as faculty. Along with seeing patients clinically, she conducts neuroimaging research related to autism spectrum disorders (ASD).
Dr. Shaffer is the director of Psychological Services for the Fragile X Treatment and Research Center. She performs evaluations necessary for clinical research and also sees patients with autism spectrum disorders (ASD), Angelman Syndrome (AS), and Fragile X Syndrome (FXS) for therapy. She has specialty training in the autism diagnostic interview- revised (ADI-R) and the autism diagnostic observation schedule (ADOS), which are both methods of diagnosing autism.
Dr. Will is a staff psychologist who conducts diagnostic interviews, evaluations, and feedback sessions both clinically and for research.
We also work with several undergraduate students who have an interest in Angelman Syndrome, Fragile X Syndrome and / or autism spectrum disorders.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462
© 1999-2021 Cincinnati Children's Hospital Medical Center. All rights reserved.